Cointime

Winston Pharmaceuticals

company

About

Winston Pharmaceuticals is engaged in the development of pain management products.

  • 11 - 50

Highlights

Total Funding Amount
$375K
Funding Rounds
1
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$375K
Industries
Biotechnology,Pharmaceutical,Therapeutics
Founded date
Jan 1, 1998
Number Of Employee
11 - 50
Operating Status
Active

Winston is a pharmaceutical company focused on developing pain management products for large pain-control markets, as well as on niche markets, where there are still significant needs for pain management options with improved efficacy, safety, and tolerability profiles. Winston’s late-stage product candidates span a range of pain indications, including episodic cluster headache, migraine and tension headache, osteo- and rheumatoid arthritis, neuropathic pain, cancer pain and pain associated with inflammatory bowel disease.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$375K
Winston Pharmaceuticals has raised a total of $375K in funding over 2 rounds. Their latest funding was raised on Apr 9, 2012 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 9, 2012 Grant $375K 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Winston Pharmaceuticals is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health — Grant
Cointime
Содержание
компания